gBRCA1/2 mutations increase the incidence of breast cancer (BC) by interrupting the homologous recombination repair (HRR) pathway. Although gBRCA1 and gBRCA2 BC have similar clinical profiles, differe
Cancer is a genetic disease caused by an accumulation of mutations, however many of these mutations have been identified in pathologically normal tissue. We aim to use laser-capture microscopy (LCM) t
Genome resequencing of B. subtilis mutant strain resulting from random recombinations between strains NCIB 3610 and RO-NN-1. Strain is mostly RO-NN-1 (~80%) but the rest includes randomly swapped snip
